A chemical probe inhibitor targeting STAT1 restricts cancer stem cell traits and angiogenesis in colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is a worldwide cancer with rising annual incidence. New medications for patients with CRC are still needed. Recently, fluorescent chemical probes have been developed for cancer imaging and therapy. Signal transducer and activator of transcription 1 (STAT1) has com...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Pei-Hsuan, Luo, Cong-Kai, Wali, Niaz, Lin, Wen-Yen, Ng, Shang-Kok, Wang, Chun-Hao, Zhao, Mingtao, Lin, Sheng-Wei, Yang, Pei-Ming, Liu, Pin-Jung, Shie, Jiun-Jie, Wei, Tzu-Tang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939146/
https://www.ncbi.nlm.nih.gov/pubmed/35313878
http://dx.doi.org/10.1186/s12929-022-00803-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939146/
https://www.ncbi.nlm.nih.gov/pubmed/35313878
http://dx.doi.org/10.1186/s12929-022-00803-4

Ejemplares similares